[HTML][HTML] Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management
ZY Ma, YF Gong, HK Zhuang, ZX Zhou… - World journal of …, 2020 - ncbi.nlm.nih.gov
Pancreatic neuroendocrine tumors (pNETs) are a heterogeneous group of tumors with
complicated treatment options that depend on pathological grading, clinical staging, and …
complicated treatment options that depend on pathological grading, clinical staging, and …
Predictive factors for resistant disease with Medical/Radiologic/Liver-directed anti-tumor treatments in patients with advanced pancreatic neuroendocrine neoplasms …
L Lee, I Ramos-Alvarez, RT Jensen - Cancers, 2022 - mdpi.com
Simple Summary Tumor resistance, both primary and acquired, is leading to increased
complexity in the nonsurgical treatment of patients with advanced panNENs, which would be …
complexity in the nonsurgical treatment of patients with advanced panNENs, which would be …
Prolonged progression‐free survival achieved by octreotide LAR plus transarterial embolization in low‐to‐intermediate grade neuroendocrine tumor liver metastases …
Y Liu, H Liu, W Chen, H Yu, W Yao, W Fan… - Cancer …, 2022 - Wiley Online Library
Objective To evaluate the efficacy and outcome of transarterial embolization (TAE) plus
octreotide long‐acting repeatable (LAR) on patients with low‐to‐intermediate …
octreotide long‐acting repeatable (LAR) on patients with low‐to‐intermediate …
Appropriate use of morphological imaging for assessing treatment response and disease progression of neuroendocrine tumors
Neuroendocrine tumors (NETs) are relatively rare neoplasms displaying heterogeneous
clinical behavior, ranging from indolent to aggressive forms. Patients diagnosed with NETs …
clinical behavior, ranging from indolent to aggressive forms. Patients diagnosed with NETs …
A nomogram to predict individual survival of patients with liver-limited metastases from gastroenteropancreatic neuroendocrine neoplasms: a US population-based …
Introduction: Although gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) with
liver metastasis encompass a wide variety of clinical conditions with various prognosis, no …
liver metastasis encompass a wide variety of clinical conditions with various prognosis, no …
Single center outcomes from parenchymal-sparing resections and microwave ablations for neuroendocrine tumor liver metastases
FT Lee, J Williams, R Nordgren, JL Schwarz… - The American Journal of …, 2024 - Elsevier
Background Reported outcomes after surgical debulking in patients with advanced
neuroendocrine tumor liver metastases (NETLM) are sparse. Methods NETLM patients that …
neuroendocrine tumor liver metastases (NETLM) are sparse. Methods NETLM patients that …
Imaging neuroendocrine tumors: Characterizing the spectrum of radiographic findings
Neuroendocrine tumors (NET) are a group of neoplasms with neuroendocrine differentiation
affecting a wide range of organs. Functional NETs present with symptoms due to the …
affecting a wide range of organs. Functional NETs present with symptoms due to the …
Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience
V Sukrithan, H Armbruster, S Rogers, SM Vogt… - Plos one, 2024 - journals.plos.org
Peptide receptor radionucleotide therapy (PRRT) with 177Lu-dotatate is widely used for the
treatment of patients with neuroendocrine tumors (NETs). We analyzed data from 104 …
treatment of patients with neuroendocrine tumors (NETs). We analyzed data from 104 …
Volumetric Enhancing Tumor Burden at CT to Predict Survival Outcomes in Patients with Neuroendocrine Liver Metastases after Intra-arterial Treatment
J Assouline, R Cannella, G Porrello… - Radiology: Imaging …, 2023 - pubs.rsna.org
Purpose To investigate whether liver enhancing tumor burden (LETB) assessed at contrast-
enhanced CT indicates early response and helps predict survival outcomes in patients with …
enhanced CT indicates early response and helps predict survival outcomes in patients with …
Analysis of tumor burden as a biomarker for patient survival with neuroendocrine tumor liver metastases undergoing intra-arterial therapies: a single-center …
M Miszczuk, J Chapiro, D Do Minh… - Cardiovascular and …, 2022 - Springer
Purpose To assess the value of quantitative analysis of tumor burden on baseline MRI for
prediction of survival in patients with neuroendocrine tumor liver metastases (NELM) …
prediction of survival in patients with neuroendocrine tumor liver metastases (NELM) …